The following table summarizes the Company’s nonperforming assets for the periods presented (in thousands):
| | | | | | |
| | June 30, | | December 31, |
| | 2020 | | 2019 |
Nonaccrual loans | | $ | 2,899 | | $ | 2,743 |
Accruing loans past due 90 days or more | | | 877 | | | 607 |
Total nonperforming loans | | | 3,776 | | | 3,350 |
Other real estate owned | | | 5,524 | | | 1,757 |
Total nonperforming assets | | $ | 9,300 | | $ | 5,107 |
Restructured loans not included above | | $ | 9 | | $ | 61 |
Potential Problem Loans
At June 30, 2020 potential problem loans amounted to approximately $551 thousand or 0.02% of total loans outstanding. Potential problem loans, which are not included in nonperforming loans, represent those loans with a well-defined weakness and where information about possible credit problems of borrowers has caused management to have doubts about the borrower’s ability to comply with present repayment terms. This definition is believed to be substantially consistent with the standards established by the Bank’s primary regulators for loans classified as substandard or worse, but not considered nonperforming loans.
COVID-19 Loan Modifications
As a result of the CARES Act, the Company began offering short-term loan modifications to assist borrowers during the COVID-19 pandemic. At June 30, 2020, COVID-19 modified loans amounted to $616.7 million, or 25.6% of the total loans outstanding.
The Company offered deferrals options of: 1) three months deferral of payment and then three months of interest only, 2) three months of interest only, 3) three months deferral of payment, 4) six months of interest only, and expects $340.6 million to mature during the third quarter of 2020, with the remainder of the balance maturing during the fourth quarter of 2020.
Included in the COVID-19 modified loans were $145.4 million and $69.3 million of hospitality and restaurant loans, respectively. These sectors had increased vulnerability from COVID-19. At June 30, 2020, the short-term loan modifications were still expected to mature on the original maturity schedule. All of the COVID-19 modified loans were transitioned into watchlist categories internally.
Allocation of the Allowance for Loan Losses
We maintain the allowance at a level that we deem appropriate to adequately cover the probable losses inherent in the loan portfolio. Our provision for loan losses for the six months ended June 30, 2020, is $6.1 million compared to $1.2 million in the same period of 2019, an increase of $4.9 million. As of June 30, 2020, and December 31, 2019, our allowance for loan losses was $16.3 million and $10.2 million, respectively, which we deemed to be adequate at each of the respective dates. The increase in the allowance for loan losses at June 30, 2020, as compared to December 31, 2019, is primarily due to the deterioration in the qualitative factors, such as unemployment and GDP, in our loan loss allowance methodology caused by the economic conditions related to the challenges being faced with the world wide COVID-19 pandemic. Our allowance for loan loss as a percentage of total loans was 0.67% at June 30, 2020 and 0.54% at December 31, 2019.
Our purchased loans were recorded at fair value upon acquisition. The fair value adjustments on the performing purchased loans will be accreted into income over the life of the loans. A provision for loan losses is recorded for any deterioration in these loans subsequent to the acquisition. As of June 30, 2020, the notional balances on PCI loans was $48.8 million while the carrying value was $35.0 million. At June 30, 2020, there were no loan loss allowances on PCI loans.